Drugmakers Turn to Chinese AI Apps to Reach Doctors

Pharmaceutical companies are increasingly using artificial intelligence applications developed in China to connect with physicians. The shift reflects drugmakers' efforts to expand their reach and engage healthcare professionals more efficiently. The reporting covers how these AI tools are being adopted as part of marketing and outreach strategies. Further details on specific companies, deal terms, and outcomes were not provided in the text supplied.